Perspectives
The modernization of life sciences compliance
A proactive approach to regulations
A modernized approach to compliance in the life sciences and pharmaceutical industry enables business leaders to stay ahead of technology regulations.
People
Jennifer Malatesta
Principal | Life Sciences
Jennifer brings more than 20 years of experience to Deloitte & Touche LLP from both the public and private sectors and is one of the leading professionals in our Life Sciences Governance Regulatory & Risk practice and a US subject matter expert on strategic risk management and compliance issues in Life Sciences. She serves Life Sciences clients, including global pharma, med tech, CROs, and public research organizations such as the NIH.
Related content
Analysis
Life Sciences Regulatory Outlook 2017
From medical devices and in-vitro diagnostics to fair market value and global transparency, explore 2017’s top life sciences regulatory compliance trends.
Perspectives
Convergence in life sciences
Traditional mergers and acquisitions aren’t the only ways to achieve convergence in the life sciences industry. Explore other trends and opportunities.